Paasa Logo
Shanghai Pharmaceuticals Holding Co., Ltd logo
2607HKSEMarket closedOpens 9:30am HKT

Shanghai Pharmaceuticals Holding Co., Ltd

HK$10.83Last updated
-HK$0.10 (0.91%)Past day
Timezone

Shanghai Pharmaceuticals Holding Co., Ltd (HKSE: 2607) is trading at HK$10.83, about ₹132 at today's HKD/INR rate, as of 25 Sep 2026, 4:08 AM ET, down 0.91% today. Indian residents can buy Shanghai Pharmaceuticals Holding from India on Paasa under the RBI's Liberalised Remittance Scheme.

Quote

Open:HK$10.86
Previous close:HK$10.93
Volume:1.07M

Today's low

HK$10.70

Today's high

HK$10.87

52 week low

HK$10.70

52 week high

HK$12.46

2607 opened at HK$10.86, closed previously at HK$10.93, and has traded between HK$10.70 and HK$12.46 over the past 52 weeks.

About

Shanghai Pharmaceuticals Holding Co., Ltd., an investment holding company based in Shanghai, People's Republic of China, maintains a robust presence across the pharmaceutical and healthcare industries. Its core activities involve the research, development, production, distribution, and retail of medical and wellness products. The company is strategically divided into Production, Distribution, Retail, and Other segments. Its comprehensive product portfolio includes Western and traditional Chinese medicines, health supplements, and medical devices, addressing a broad spectrum of therapeutic areas such as oncology, cardiovascular health, central nervous system disorders, general infections, immunology, digestive and metabolic conditions, and respiratory ailments, totaling approximately 700 distinct drug varieties. Beyond manufacturing, Shanghai Pharmaceuticals offers extensive pharmaceutical supply chain solutions, encompassing warehousing, logistics, and value-added services for manufacturers, hospitals, distributors, and retail pharmacies. The company also boasts a significant retail footprint, operating a network of approximately 2,000 retail pharmacies across 24 provinces, alongside an active online drug business. Furthermore, it provides various specialized services, including consulting, asset management, clinical trials, medical aid programs, physician and patient education, e-prescription management, and remote/cloud-based hospital services. Established in 1994, Shanghai Pharmaceuticals Holding Co., Ltd. operates as a subsidiary of Shanghai Pharmaceutical (Group) Co., Ltd.

Country
CN
CEO
Qiuhua Yang
Exchange listed on
HKSE
Industry
Medical - Distribution
Base currency
HKD
Full Time Employees
49,608
Sector
Healthcare
IPO date
20/05/2011

Key statistics

Avg. volume

2.23M

Market cap

HK$62.82B

P/E Ratio

12.42

Price-to-sales ratio

0.21

Enterprise value

CN¥90.53B

Free cash flow yield

12.93%

Debt-to-equity ratio

0.84

Return on equity

6.21%

ROIC

3.64%

Beta

0.22

Dividend yield

3.56%

Last dividend

HK$0.54

Financial overview

Revenue

CN¥283.58B

Earnings per share

CN¥1.54

Free cash flow

CN¥3.83B

Net profit margin

1.65%

Gross margin

10.79%

EBITDA

CN¥14.37B

Revenue growth

3.03%

Similar securities

This is not an investment recommendation

How to buy Shanghai Pharmaceuticals Holding from India

Indian residents can buy Shanghai Pharmaceuticals Holding shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.

  1. Open a Paasa account

    Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.

  2. Add funds under LRS

    Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars and then to HKD.

  3. Search for Shanghai Pharmaceuticals Holding and place an order

    Find Shanghai Pharmaceuticals Holding by name or by its ticker, 2607, and choose an order type. Many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share. Shanghai Pharmaceuticals Holding trades 7:00 am – 1:30 pm IST; orders can only execute during that window.

  4. Track holdings and download tax reports

    Follow your Shanghai Pharmaceuticals Holding position in HKD and INR, and use Paasa's capital-gains and dividend statements when you file your Indian return.

Read the full guide: how to invest in Shanghai Pharmaceuticals Holding from India

Trading and taxes when buying Shanghai Pharmaceuticals Holding from India

Trading and limits

Trading hours
9:30 am – 4:00 pm HKT
LRS limit
$250,000Per financial year, under the RBI's Liberalised Remittance Scheme.

Tax for Indian residents

TCS on remittance
20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
Capital gains in India
12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
Dividends
Slab rateDividends are taxed at your slab rate in India. Shanghai Pharmaceuticals Holding’s current yield is 3.56%.Dividend tax explained

Custody. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.

FAQs

Can Indian residents buy Shanghai Pharmaceuticals Holding stock?

Yes. Shanghai Pharmaceuticals Holding (2607) has been listed on the Hong Kong Stock Exchange since 2011, in the Medical - Distribution industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars and then to HKD. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.

How much does one Shanghai Pharmaceuticals Holding share cost in rupees?

One Shanghai Pharmaceuticals Holding share is HK$10.83 — about ₹132 at an HKD/INR rate of 12.23 on 26 Sep 2026. Both the Shanghai Pharmaceuticals Holding price and the rupee rate move during the day, so the rupee cost changes with them.

What are the LRS and TCS rules for buying Shanghai Pharmaceuticals Holding from India?

Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.

What is the minimum I can buy of Shanghai Pharmaceuticals Holding?

Many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share.

How are gains on Shanghai Pharmaceuticals Holding shares taxed in India?

Hong Kong generally does not levy capital gains tax on non-resident individual investors for HKEX-listed stocks, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the HKD/INR rate on the purchase and the sale date, so the rupee move counts alongside the Shanghai Pharmaceuticals Holding price. Paasa issues a capital-gains statement for your return.

Does Shanghai Pharmaceuticals Holding pay a dividend, and how is it taxed in India?

Yes. Shanghai Pharmaceuticals Holding pays a dividend and the current yield is 3.56%; the last declared dividend was HK$0.54 per share, about ₹6.57. Dividends are taxed at your slab rate in India. Paasa's dividend report lists the gross dividend and any tax withheld for each payment.

When can I trade Shanghai Pharmaceuticals Holding from India?

The Hong Kong Stock Exchange trades 7:00 am – 1:30 pm IST in Indian time. It also halts for lunch, 9:30 am – 10:30 am IST. Orders can only execute during that window.

Is Shanghai Pharmaceuticals Holding a Hong Kong SAR China company, and does that change how it is taxed?

Shanghai Pharmaceuticals Holding trades on the Hong Kong Stock Exchange in HKD, but the company is domiciled in China. Shanghai Pharmaceuticals Holding trades as an ordinary share listed directly in Hong Kong, not a depositary receipt. Your India-side capital-gains treatment is the same either way.

Do I have to declare Shanghai Pharmaceuticals Holding shares in my Indian tax return?

Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Shanghai Pharmaceuticals Holding holding, its cost and its closing value.

How do I sell Shanghai Pharmaceuticals Holding and bring the money back to India?

You sell during market hours (7:00 am – 1:30 pm IST) and the proceeds settle in HKD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.